Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Bugelski

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Cellular Immunology|November 1, 1990
Humoral response of cynomolgus macaques to human soluble CD4: antibody reactivity restricted to xeno-human determinantsA Truneh, R L Frescatore, P Thiem, et al.
Human & Experimental Toxicology|August 5, 2000
Repeated acetaminophen dosing in rats: adaptation of hepatic antioxidant systemP J O'Brien, M R Slaughter, A Swain, et al.
Thrombosis and Haemostasis|April 12, 1990
Internalization of recombinant tissue-type plasminogen activator by isolated rat hepatocytes is via coated pitsG J Marks, T K Hart, G F Rush, et al.
AIDS Research and Human Retroviruses|December 1, 1992
Strong association of simian immunodeficiency virus (SIVagm) envelope glycoprotein heterodimers: possible role in receptor-mediated activationJ S Allan, E M Whitehead, K Strout, et al.
The Journal of Rheumatology|March 1, 1994
Effects of a novel azaspirane (SK&F 105685) on arthritic lesions in the adjuvant Lewis rat: attenuation of the inflammatory process and preservation of skeletal integrityW B High, P J Bugelski, M E Nichols, et al.
Toxicology|January 6, 1995
Effect of TNF alpha production inhibitors BRL 61063 and pentoxifylline on the response of rats to poly I:CJ M Kaplan, D J Herzyk, E V Ruggieri, et al.
Toxicology and Applied Pharmacology|August 17, 1999
Selective inhibition of phospholipases by atiprimod, a macrophage targeting antiarthritic compoundJ A Handler, A Badger, C A Genell, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1995
Separation of immunomodulatory and cholesterol-lowering activities of heterocyclic azaspiranesC R Albrightson, P J Bugelski, T A Berkhout, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 1, 1995
Renal catabolism of recombinant human soluble CD4 after intravenous administration to male Sprague-Dawley ratsT W Hepburn, C B Davis, J J Urbanski, et al.
International Journal of Immunopharmacology|May 29, 1999
Atiprimod (SK&F 106615), a novel macrophage targeting agent, enhances alveolar macrophage candidacidal activity and is not immunosuppressive in Candida-infected miceA M Badger, J A Handler, C A Genell, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Cellular Immunology|November 1, 1990
Humoral response of cynomolgus macaques to human soluble CD4: antibody reactivity restricted to xeno-human determinantsA Truneh, R L Frescatore, P Thiem, et al.
Human & Experimental Toxicology|August 5, 2000
Repeated acetaminophen dosing in rats: adaptation of hepatic antioxidant systemP J O'Brien, M R Slaughter, A Swain, et al.
Thrombosis and Haemostasis|April 12, 1990
Internalization of recombinant tissue-type plasminogen activator by isolated rat hepatocytes is via coated pitsG J Marks, T K Hart, G F Rush, et al.
AIDS Research and Human Retroviruses|December 1, 1992
Strong association of simian immunodeficiency virus (SIVagm) envelope glycoprotein heterodimers: possible role in receptor-mediated activationJ S Allan, E M Whitehead, K Strout, et al.
The Journal of Rheumatology|March 1, 1994
Effects of a novel azaspirane (SK&F 105685) on arthritic lesions in the adjuvant Lewis rat: attenuation of the inflammatory process and preservation of skeletal integrityW B High, P J Bugelski, M E Nichols, et al.
Toxicology|January 6, 1995
Effect of TNF alpha production inhibitors BRL 61063 and pentoxifylline on the response of rats to poly I:CJ M Kaplan, D J Herzyk, E V Ruggieri, et al.
Toxicology and Applied Pharmacology|August 17, 1999
Selective inhibition of phospholipases by atiprimod, a macrophage targeting antiarthritic compoundJ A Handler, A Badger, C A Genell, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1995
Separation of immunomodulatory and cholesterol-lowering activities of heterocyclic azaspiranesC R Albrightson, P J Bugelski, T A Berkhout, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 1, 1995
Renal catabolism of recombinant human soluble CD4 after intravenous administration to male Sprague-Dawley ratsT W Hepburn, C B Davis, J J Urbanski, et al.
International Journal of Immunopharmacology|May 29, 1999
Atiprimod (SK&F 106615), a novel macrophage targeting agent, enhances alveolar macrophage candidacidal activity and is not immunosuppressive in Candida-infected miceA M Badger, J A Handler, C A Genell, et al.
Pageof 7